In our November issue of Pharmaceutical Executive
FEATURES
Cover Story
Pharm Exec's 2016 Pipeline Report
Casey McDonald
Falling enterprise values and the drug pricing controversy have defined the life sciences landscape during the waning days of 2015. Will a pipeline harvest full of treatments founded on strong science, supportive regulation, and unmet medical need offer solace to shareholders and the promise of a reputational rebound? |
From the Editor
Twisting the Spigot: This Year’s Pipeline Report
William Looney
Building on our annual look at the industry's product pipeline, four key themes stand out that are driving the fast-changing environment for drug development, writes William Looney. |
Logistics
The Push for a Pull Supply Chain
Julian Upton
Experts are warning that if pharma doesn't take a tighter grip on its supply chain and yank it into the 21st century, the industry could soon face distribution and logistics crises on an unprecedented scale. |
Biotechnology
Rewriting the Book of Life: A New Era in Precision Gene Editing
Jeff Liepman, Kevin Barnett, Kun Lee, Nathan Lyman
With the recent wave of targeted therapy approvals and more biomarker-driven treatments on the horizon, properly commercializing biopharma drugs paired with a companion diagnostic can be a competitive differentiator. Four "can't miss" strategies for successfully managing the development, launch, and commercialization of Rx-CDx pairings are outlined here. |
Marketing
Think Globally, Act Locally
Eric Bernabei, Nancy Beesley
We now have the capacity with the click of a button to disseminate our message all over the world, instantaneously. But as marketers, we know the path from globalization to localization is an important one, in which steps can't be skipped. So what are the keys to getting a global message to become a local message in today’s digital world?
|
 |
ALSO IN THIS ISSUE
Market Access Reinvented
Peter Vanovertveld, Thomas Bertels
The key steps to implementing the "patient access" model of the future.
The 'Prosolidate' Push: New Agency Service Mix
Elizabeth Izard Apelles
Examining the advantages for brand teams in leveraging independent agencies in their campaigns.
Drug-Pricing Backlash Reaches Fever Pitch
Jill Wechsler
Doctors, activists, politicians, and the Feds jump on price-gouging bandwagon.
Strength From the Few
Casey McDonald
Rare disease supporters deliver inspiration and optimism—as well as promise of regulatory cooperation.
|
| |
| WEBCASTS |
| New Tufts CSDD Research: Industry Adoption of eClinical Solutions and CDISC Standards
|
| The Growing Aging Consumer Population – Living Longer, Living Smarter |
Engineer Your Business to Win in the Mobile Selling Moment
|
| |
